HomeNewswire

Newswire

TG Therapeutics Reveals Phase 1 Azer-cel Data for MS

TG Therapeutics Reveals Phase 1 Azer-cel Data for MS

November 9, 2026

SM Investments Secures Third Consecutive Five Golden Arrow Award

SM Investments Secures Third Consecutive Five Golden Arrow Award

November 9, 2026

Paylocity Exceeds Q1 Revenue Expectations and Raises 2027 Guidance

Paylocity Exceeds Q1 Revenue Expectations and Raises 2027 Guidance

November 9, 2026

Qiagen Partners with Singapore in Precision Medicine Effort

Qiagen Partners with Singapore in Precision Medicine Effort

November 9, 2026

Iovance Biotherapeutics Exceeds Q3 Expectations with Robust Amtagvi Sales

Iovance Biotherapeutics Exceeds Q3 Expectations with Robust Amtagvi Sales

November 9, 2026

Refining Stocks Surge in 2026 Amid Global Supply Constraints

Refining Stocks Surge in 2026 Amid Global Supply Constraints

November 8, 2026

Oligonucleotide Synthesis Market to Reach $4.7 Billion by 2030

Oligonucleotide Synthesis Market to Reach $4.7 Billion by 2030

November 8, 2026

Jonathan M. Pratt Joins QIAGEN’s Managing Board After Shareholder Approval

Jonathan M. Pratt Joins QIAGEN’s Managing Board After Shareholder Approval

November 8, 2026

Agenus Reports Q3 Earnings in Line, Revenue Falls Short

Agenus Reports Q3 Earnings in Line, Revenue Falls Short

November 8, 2026

Exploring Key Midstream Pipeline Stocks Amid Oil Market Shifts

Exploring Key Midstream Pipeline Stocks Amid Oil Market Shifts

November 8, 2026

1 2 3 … 8 »